Original page created in 2003. Updated by Dr Thomas Stewart, General Practitioner, Sydney, Australia. DermNet Editor in Chief: Adjunct A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell. April 2018.
Tinea pedis is a foot infection due to a dermatophyte fungus. It is the most common dermatophyte infection and is particularly prevalent in hot, tropical, urban environments.
Interdigital involvement is most commonly seen (this presentation is also known as athlete’s foot, although some people use the term for any kind of tinea pedis).
Tinea pedis usually occurs in males and adolescents/young adults, but can also affect females, children and older people. Infection is usually acquired by direct contact with the causative organism, for example using a shared towel, or by walking barefoot in a public change room.
Other risk factors include:
Occlusive footwear (for example, heavy industrial boots)
Tinea pedis tends to be asymmetrical, and may be unilateral. It usually presents in one of three ways:
Itchy erosions and/or scales between the toes, especially between 4th and 5th toes
Scale covering the sole and sides of the feet (hyperkeratotic/moccasin type, usually caused by T. rubrum)
Small to medium-sized blisters, usually affecting the inner aspect of the foot (vesiculobullous type).
It can also uncommonly cause oozing and ulceration between the toes (ulcerative type), or pustules (these are more common in tinea pedis due to T. interdigitale than that due to T. rubrum).
How is the diagnosis of tinea pedis made?
The diagnosis of tinea pedis can be made clinically in most cases, based on the characteristic clinical features. Other typical sites, such as toenails, groin, and palms of the hands, should be examined for fungal infection, which may support a diagnosis of tinea pedis.
Diagnosis is confirmed by skin scrapings, which are sent for microscopy in potassium hydroxide (when segmented hyphae may be observed) and culture (mycology). Culture may not be necessary if typical fungal elements are observed on microscopy.
What is the differential diagnosis of tinea pedis?
The differential diagnosis of tinea pedis includes:
These inflammatory disorders are more likely to be symmetrical and bilateral.Mycology is negative.
What is the treatment for tinea pedis?
General measures should be first-line, including meticulous drying of feet, especially between the toes, avoidance of occlusive footwear, and the use of barrier protection (sandals) in communal facilities. Finger socks can help separate the toes, reducing humidity and help clear infection.
Topical antifungal therapy once or twice daily is usually sufficient. These include azoles, allylamines, butenafine, ciclopirox, and tolnaftate. A typical course is 2 to 4 weeks, but single dose regimes can be successful for mild infection [1,2].
For those who do not respond to topical therapy, an oral antifungal agent may be needed for a few weeks. These include:
Griseofulvin (this may be inferior to other oral agents and may not be available in some countries) [3,4].
Patients with the hyperkeratotic variant of tinea pedis may benefit from the addition of a topical keratolyticcream containing salicylic acid or urea [5].
How can recurrence of tinea pedis be prevented?
To minimise recurrence of tinea pedis:
Dry feet and toes meticulously after bathing
Use desiccating foot powder once or twice daily
Avoid wearing occlusive footwear for long periods
Thoroughly dry shoes and boots
Clean the shower and bathroom floors using a product containing bleach
Treat shoes with antifungal powder.
If treatment of tinea pedis is unsuccessful, consider reinfection, coexistent untreated fungal nail infection, reinfection due to untreated family member, or an alternative diagnosis.
References
Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2007; 18(3): CD001434. PubMed
Korting HC, Tietz HJ, Bräutigam M, Mayser P, Rapatz G, Paul C. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group. Med Mycol. 2001; 39(4): 335–40. PubMed
Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008; 166 (5-6): 353. DOI: 10.1007/s11046-008-9109-0.PubMed
Bell-Syer SE, Khan SM, Torgerson DJ. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev. 2012; 10: CD003584. PubMed
Kircik LH, Onumah N. Use of naftifine hydrochloride 2% cream and 39% urea cream in the treatment of tinea pedis complicated by hyperkeratosis. J Drugs Dermatol. 2014 Feb. 13(2): 162–5. Journal